These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 9641689

  • 1. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.
    Circulation; 1998 Jun 23; 97(24):2386-95. PubMed ID: 9641689
    [Abstract] [Full Text] [Related]

  • 2. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav JS, Pieper KS, Gallup D, Dyke C, Roe MT, Berdan L, Lauer MS, Mänttäri M, White HD, Califf RM, Topol EJ.
    Am Heart J; 2002 Dec 23; 144(6):995-1002. PubMed ID: 12486423
    [Abstract] [Full Text] [Related]

  • 3. Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
    Alexander JH, Harrington RA.
    Drugs; 1998 Dec 23; 56(6):965-76. PubMed ID: 9878986
    [Abstract] [Full Text] [Related]

  • 4. Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.
    Théroux P, Kouz S, Roy L, Knudtson ML, Diodati JG, Marquis JF, Nasmith J, Fung AY, Boudreault JR, Delage F, Dupuis R, Kells C, Bokslag M, Steiner B, Rapold HJ.
    Circulation; 1996 Sep 01; 94(5):899-905. PubMed ID: 8790023
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.
    N Engl J Med; 1998 May 21; 338(21):1488-97. PubMed ID: 9599103
    [Abstract] [Full Text] [Related]

  • 6. Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee.
    Moliterno DJ.
    Am Heart J; 2000 Apr 21; 139(4):563-6. PubMed ID: 10740135
    [Abstract] [Full Text] [Related]

  • 7. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Eur Heart J; 1998 Apr 21; 19 Suppl D():D10-21. PubMed ID: 9597518
    [Abstract] [Full Text] [Related]

  • 8. Lamifiban.
    Dooley M, Goa KL.
    Drugs; 1999 Feb 21; 57(2):215-21; discussion 222-3. PubMed ID: 10188762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators.
    N Engl J Med; 1998 May 21; 338(21):1498-505. PubMed ID: 9599104
    [Abstract] [Full Text] [Related]

  • 12. Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial.
    J Am Coll Cardiol; 1998 Dec 21; 32(7):2003-10. PubMed ID: 9857885
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
    Lauer MA, Houghtaling PL, Peterson JG, Granger CB, Bhatt DL, Sapp SK, Simoons ML, Harrington RA, Topol EJ, Lincoff AM, Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
    Circulation; 2001 Dec 04; 104(23):2772-7. PubMed ID: 11733393
    [Abstract] [Full Text] [Related]

  • 14. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
    Akkerhuis KM, Neuhaus KL, Wilcox RG, Vahanian A, Boland JL, Hoffmann J, Baardman T, Nehmiz G, Roth U, Klootwijk AP, Deckers JW, Simoons ML, Fibrinogen Receptor Occupancy Study (FROST) Investigators.
    Eur Heart J; 2000 Dec 04; 21(24):2042-55. PubMed ID: 11102255
    [Abstract] [Full Text] [Related]

  • 15. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T, Theroux P, Snapinn S, Wan Y, Montreal General Hospital, Montreal, Quebec, Canada. thao.huynh@muhc.mcgill.ca.
    Am Heart J; 2003 Oct 04; 146(4):668-73. PubMed ID: 14564321
    [Abstract] [Full Text] [Related]

  • 16. Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
    Théroux P, Alexander J, Pharand C, Barr E, Snapinn S, Ghannam AF, Sax FL.
    Circulation; 2000 Nov 14; 102(20):2466-72. PubMed ID: 11076818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYMPHONY) trial. Symphony Steering Committee.
    Newby LK.
    Am Heart J; 1999 Aug 14; 138(2 Pt 1):210-8. PubMed ID: 10426831
    [Abstract] [Full Text] [Related]

  • 20. Newer antiplatelet agents in acute coronary syndromes.
    White HD.
    Am Heart J; 1999 Dec 14; 138(6 Pt 2):S570-6. PubMed ID: 10577464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.